The Challenge
A 173-year-old company. Nearly 80,000 global colleagues. All united by one urgent mission: bring a vaccine to market to help mitigate the worst pandemic in 100 years. There were a lot of hurdles to get the vaccine to market. Research. Clinical trials. Manufacturing. Approvals. Distribution. At the end of 2020, Pfizer's dedication paid off: The company submitted for Emergency Use Approval for its mRNA COVID-19 vaccine. In December of 2021, in honor of the one-year anniversary of this historic accomplishment, Pfizer's enterprise colleague communications team, in partnership with M Booth, wanted to acknowledge, recognize, and surprise the Pfizer...